PrisMax V3

The NIH Clinical Center is procuring additional renal replacement therapy equipment for its newly established Pediatric Intensive Care Unit (PICU). The solicitation is a sole‑source justification to purchase one PrisMax V3 CRRT system, a TherMax Blood Warmer, and a PrisMax Warmer Arm Kit from the exclusive manufacturer Vantive. The total acquisition cost is $32,868.25. The equipment will integrate with the Center’s existing electronic health record (CRIS) and maintain consistency across all CRRT devices used in research protocols. • Item: 1 × PrisMax V3 (US) • Item: 1 × TherMax Blood Warmer accessory • Item: 1 × PrisMax Warmer Arm Kit • Total cost: $32,868.25 (sole‑source) • Purpose: Support continuous renal replacement therapy (CRRT) and therapeutic plasma exchange (TPE) for pediatric patients ≥20 kg in the PICU • Rationale: Only Vantive’s PrisMax meets the required modes (CVVHDF, CVVHD, CVVH, SCUF) and integrates with the hospital’s CRIS EHR; no alternative equipment satisfies the clinical and research consistency requirements.